Alvotech and Advanz Pharma Partner to Commercialize Biosimilar Eylea® Candidates in Europe

  Alvotech  a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz P...

June 18, 2024 | Tuesday | News
ChargePoint Technology Launches Innovative Robotic Material Handling Solution for Pharma Industry

ChargePoint Technology, a powder and liquid transfer specialist, has announced the launch of a new robotic material handling solution aimed at increasing s...

June 11, 2024 | Tuesday | News
Essential Pharma Partners with AGC Biologics for Late-Phase Manufacturing of Promising Neuroblastoma Immunotherapy

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk...

June 11, 2024 | Tuesday | News
AstraZeneca's TROPION-Lung01 Trial Reveals Datopotamab Delxtecan's Potential as New Treatment Option for Advanced Lung Cancer

TROPION-Lung01 Phase III trial had a local progressive or metastatic non-small cell lung cancer with at least one treatment history in the past ( Datopot...

May 29, 2024 | Wednesday | News
EU-Funded Project by Bio-Sourcing, Ciloa, and Intract Pharma Targets Inflammatory Diseases

  AB-BIOBETTER, led by Bio-Sourcing, to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering patient...

May 28, 2024 | Tuesday | News
BenevolentAI & AstraZeneca Unveil Novel Heart Failure Target

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma ...

May 15, 2024 | Wednesday | News
Siemens Healthineers Announces New Global Center for Low-Helium MRI Technology in Oxfordshire, Marking a Milestone in Sustainable Healthcare Innovation

  The new facility will focus on the production of Siemens Healthineers’ pioneering DryCool MRI magnets, which drastically reduce the amount of...

May 13, 2024 | Monday | News
Johnson & Johnson Unifies Business Segments, Enhancing Healthcare Solutions in the UK

Johnson & Johnson announced it is updating its brand and uniting both its two business segments under the Johnson & Johnson brand name in the UK. ...

May 01, 2024 | Wednesday | News
ChargePoint Technology Invests in New Manufacturing Facility to Meet Growing Demand for Single-Use Solutions

  ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-u...

April 24, 2024 | Wednesday | News
AviadoBio Initiates Phase 1/2 Trial for Gene Therapy in Frontotemporal Dementia

-AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, ...

April 15, 2024 | Monday | News
EnteroBiotix Completes £27 Million Funding Round to Advance Microbiome Therapeutics for Gut Disorders

EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics,  announced th...

April 04, 2024 | Thursday | News
 Scotland to Host Research Challenge Using the Most Comprehensive Set of Dementia Biomarker Data in the World

  The Global Alzheimer's Platform Foundation® (GAP) has announced that Scotland will host the Bio-Hermes Biomarker Data Challenge 2024, a groundb...

March 26, 2024 | Tuesday | News
Orchard Therapeutics Achieves Landmark FDA Approval for Lenmeldy™, Pioneering Gene Therapy for Early-onset Metachromatic Leukodystrophy

Orchard Therapeutics, now under the stewardship of Kyowa Kirin, announces a historic milestone as the U.S. Food and Drug Administration (FDA) grants approv...

March 19, 2024 | Tuesday | News
Fennec and Norgine Partner to Commercialize PEDMARQSI in Europe, Australia, and NZ

Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI®, the first and only approved therapy in the Europea...

March 18, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close